Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells

Clinical and Experimental Allergy

Volumn 27, Issue 10, 1997, Pages 1167-1174

  Molet, S ^a   Gosset, P ^a   Lassalle, P ^a   Czarlewski, W ^b   Tonnel, A B ^a,c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

^c INSERM   (France)

Author keywords

Allergy; H1 receptor antagonist; Histamine; Human endothelial cells; IL 8; Interleukin (IL) 6; P selectin

Indexed keywords

CYTOKINE; DESLORATADINE; DRUG METABOLITE; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 6; INTERLEUKIN 8; LORATADINE; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LORATADINE; P-SELECTIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0030819485     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01154.x     Document Type: Article

References (34)

1. Temple DM, McClusckey M. Loratadine, an antihistamine, blocks antigen- and ionophore-induced leukotriene release from human lung in vitro. Prostaglandins 1988: 35:549-55.
2. Kreutner W, Chapman RW, Gulbenkian A, Siegel MI. Antiallergic activity of loratadine, a non-sedating antihistamine. Allergy 1987: 42:57-63.
3. Miadonna A, Milazzo N, Lorini M, Marchesi E, Tedeschi A. Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils. Int Arch Allergy Immunol 1994: 105:12-7.
4. Eda R, Sugiyama H, Hopp RJ, Bewtra AK, Townley RG. Effect of loratadine on human eosinophil function in vitro. Annals of Allergy 1993: 71:373-8.
5. Cuss F, Gulbenkian A, Egan R, Danzig M, Kreutner W. Eosinophilia in nasal and bronchial lavage is inhibited by loratadine. Clin Exp Allergy 1990; 20s (abstr): 57.
6. Bousquet J, Lebel B, Chanal I, Morel A, Michel FB. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol 1988: 82:881-7.
7. Anderson M, Nolte H, Baumgarten C, Pipkorn U. Suppressive effects of loratadine on allergen-induced histamine release in the nose. Allergy 1991: 46:540-6.
8. Vignola AM, Crampette L, Mondain M, Sauvère G, Michel FB, Czarlewski W, Bousquet J, Campbell AM. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995: 50:200-3.
9. Dugas B, Arock M, Czarlewski W, Bousquet J. Activation of membrane markers from purified human eosinophils by histamine. Abstract AAAI 1994.
10. Loratadine. Drugs of the Future. 1987: 12:544-9.
11. Barenholtz HA, McLeod DC. Loratadine: a nonsedating antihistamine with once-daily dosing. DICP 1989: 23:445-50.
12. Schleimer RP, McGlashan DW Jr, Peters SP, Naclerio R, Proud D, Adkinson NF Jr, Lichtenstein LM. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol 1984: 74:473-81.
13. Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmermann GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991: 115:223-34.
14. Delneste Y, Gosset P, Jeannin P, Lassalle P, Joseph M, Tonnel AB. Histamine induces IL-6 production by human endothelial cells. Clin Exp Immunol 1994: 98:344-9.
15. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, Tonnel AB. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994: 84:2229-33.
16. Jaffe EA, Nachman RL, Becker CB, Minick CR. Culture of human endothelial cells derived from human umbilical veins. J Clin Invest 1973: 52:2745-56.
17. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986: 137:1893-6.
18. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994: 94:1147-55.
19. Vannier E, Miller LC, Dinarello CA. Histamine suppresses gene expression and synthesis of tumor necrosis factor α via histamine H2 receptors. J Exp Med 1991: 174:281-4.
20. Vannier E, Dinarello CA. Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. J Clin Invest 1993: 92:281-7.
21. Bourne HR, Melmon KL, Lichtenstein LM. Histamine augments leukocyte adenosine 3′, 5′-monophosphate and blocks antigenic histamine release. Science 1971: 173:743-5.
22. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989: 84:92-9.
23. Khew-Goodall Y, Butcher CM, Litwin MS, Newland S, Korpelainen EI, Noack LM, Berndt MC, Lopez AF, Gamble JR, Vadas MA. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 1996; 1432-8.
24. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmerman GA, McEver RP. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990: 343:757-60.
25. Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med 1994: 180:371-6.
26. Gosset P, Malaquin F, Delneste Y, Wallaert B, Capron A, Joseph M, Tonnel AB. IL-6 and IL-1α production is associated with antigen-induced late nasal response. J Allergy Clin Immunol 1993: 92:878-90.
27. Lee CE, Neuland ME, Teaford HG, Villacis BF, Dixon PS, Valtier S, Yeh CH, Fournier DC, Charlesworth EN. Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 1992: 89:1010-20.
28. Choi I, Kang HS, Yang Y, Pyun KH. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol 1994: 95:530-5.
29. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994: 368:339-42.
30. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989: 243:1464-6.
31. Leonard EJ, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D. Leukocyte specificity and binding of neutrophil attractant/activation protein-1. J Immunol 1990: 144:1323-30.
32. Warringa RAJ, Koenderman L, Kok PTM, Kreukniet J, Bruijnzeel PLB. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991: 77:2694-700.
33. Kuna P, Reddigari SR, Kornfeld D, Kaplan AP. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol 1991: 147:1920-4.
34. White MV, Yoshumira T, Hook W, Kaliner MA, Leonard EJ. Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. Immunol Lett 1989: 22:151-4.